跳至主要内容
临床试验/NCT05645991
NCT05645991已完成不适用

Effects of Novel Coconut Inflorescence Sap (CSP; COCOZEN) on Age-related Cardiovascular Function

Ball State University1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2018年3月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
1
主要终点
Change in systolic and diastolic brachial blood pressure

研究概览

简要总结

The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by carotid-femoral pulse wave velocity, resting brachial and (non-invasive) carotid blood pressure, and carotid stiffness (e.g. Beta stiffness index, Carotid compliance, Elastic modulus, Distensibility).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Body mass index 18-35 kg/m2
  • •Brachial blood pressure <140/90
  • •Nonsmoker
  • •No known clinical disease, or suggestive signs or symptoms of clinical disease
  • •Free of alcohol or drug dependence

排除标准

  • •taking any anti-hypertensive, lipid lowering or other cardiovascular altering medications
  • •Known allergies to coconut or tree nuts (i.e., cashews, almonds, or pistachios)
  • •Engaging in vigorous intensity exercise

研究组 & 干预措施

Placebo

Placebo Comparator

Capsules containing aspartame (1.5 g/day) were taken orally once daily for 8 weeks.

干预措施: Placebo (Dietary Supplement)

Coconut Sap Powder

Experimental

Capsules containing coconut sap powder (CSP; 1.5 g/day) were taken orally once daily for 8 weeks.

干预措施: Coconut Sap Powder (CSP) (Dietary Supplement)

结局指标

主要结局

Change in systolic and diastolic brachial blood pressure

时间窗: Baseline and 8 weeks

Manual sphygmomanometer (mmHg)

Change in carotid artery stiffness - beta stiffness index

时间窗: Baseline and 8 weeks

Carotid artery Beta stiffness index (AU)

Change in carotid systolic and diastolic blood pressure

时间窗: Baseline and 8 weeks

Applanation tonometry of carotid artery (mmHg)

Change in carotid artery stiffness - distensibility

时间窗: Baseline and 8 weeks

Carotid artery distensibility (10\^-3/kilopascals)

Change in aortic stiffness

时间窗: Baseline and 8 weeks

Carotid-femoral pulse wave velocity (meters/second)

Change in carotid artery stiffness - carotid compliance

时间窗: Baseline and 8 weeks

Carotid artery carotid compliance (mmHg/mm\^2)

Change in carotid artery stiffness - elastic modulus

时间窗: Baseline and 8 weeks

Carotid artery elastic modulus (kilopascals, kPa)

Change in carotid artery stiffness - Young's modulus

时间窗: Baseline and 8 weeks

Carotid artery Young's modulus (kilopascals, kPa)

次要结局

  • Change in inflammatory biomarker - tumor necrosis factor alpha(Baseline and 8 weeks)
  • Change in inflammatory biomarker - high sensitivity C-reactive protein(Baseline and 8 weeks)
  • Change in oxidative stress biomarkers - Catalase(Baseline and 8 weeks)
  • Change in oxidative stress biomarkers - Oxidized low density lipoprotein(Baseline and 8 weeks)
  • Change in inflammatory biomarker - interleukin 6(Baseline and 8 weeks)
  • Change in inflammatory biomarker - interleukin 10(Baseline and 8 weeks)
  • Change in inflammatory biomarker - interleukin 1 beta(Baseline and 8 weeks)
  • Change in inflammatory biomarker - monocyte chemoattractant protein 1(Baseline and 8 weeks)
  • Change in oxidative stress biomarkers - superoxide dismutase(Baseline and 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brad Fleenor

Associate Professor

Ball State University

研究点 (1)

Loading locations...

相似试验